GBA1 and Parkinson disease: Owing to the high prevalence of GBA1 mutations among PD patients and the similarity of pathology between GBA1 mutation-associated PD and sporadic PD, investigating the biological underpinnings of the pathological changes associated with GBA1 mutations and developing GCase-targeted therapeutics are areas of development for PD research.